We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

99 hedge funds and large institutions have $657M invested in GenMark Diagnostics, Inc in 2017 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 50 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

285% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 13

217% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 6

15% more funds holding

Funds holding: 86 → 99 (+13)

6% more capital invested

Capital invested by funds: $618M → $657M (+$39.6M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
99
Holders Change
+13
Holders Change %
+15.12%
% of All Funds
2.47%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
19
Increased
50
Reduced
13
Closed
6
Calls
$58K
Puts
–
Net Calls
+$58K
Net Calls Change
-$8K

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$12.3M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$12.2M
3
CCM
Cadian Capital Management
New York
+$10.2M
4
JP Morgan Chase
JP Morgan Chase
New York
+$7.15M
5
MWNA
Marshall Wace North America
New York
+$6.59M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$8.31M
2
CRC
Curi RMB Capital
Illinois
-$6.41M
3
Morgan Stanley
Morgan Stanley
New York
-$4.02M
4
Two Sigma Investments
Two Sigma Investments
New York
-$1.1M
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$536K
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
51
California Public Employees Retirement System
California
$600K – – –
NIM
52
Needham Investment Management
New York
$592K +$639K +50,000 New
RhumbLine Advisers
53
RhumbLine Advisers
Massachusetts
$573K +$5.22K +408 +0.8%
Baird Financial Group
54
Baird Financial Group
Wisconsin
$549K – – –
Ameriprise
55
Ameriprise
Minnesota
$510K +$118K +9,196 +27%
AQR Capital Management
56
AQR Capital Management
Connecticut
$471K +$83.5K +6,534 +20%
Manulife (Manufacturers Life Insurance)
57
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$426K +$18K +1,410 +4%
CM
58
Crestline Management
Texas
$426K +$461K +36,046 New
LP
59
LMR Partners
United Kingdom
$410K +$443K +34,655 New
TI
60
Trexquant Investment
Connecticut
$371K +$401K +31,386 New
MLICM
61
Metropolitan Life Insurance Company (MetLife)
New York
$343K – – –
AIG
62
American International Group
New York
$322K +$30.1K +2,356 +9%
State Board of Administration of Florida Retirement System
63
State Board of Administration of Florida Retirement System
Florida
$314K +$120K +9,418 +55%
CS
64
Credit Suisse
Switzerland
$313K +$52.8K +4,129 +18%
NFA
65
Nationwide Fund Advisors
Ohio
$294K -$14K -1,097 -4%
UBS AM
66
UBS AM
Illinois
$277K +$299K +23,400 New
VOYA Investment Management
67
VOYA Investment Management
Georgia
$233K +$37.6K +2,943 +18%
RJA
68
Raymond James & Associates
Florida
$210K +$227K +17,750 New
BFM
69
Boothbay Fund Management
New York
$165K +$178K +13,954 New
QSS
70
Quantitative Systematic Strategies
Florida
$159K +$26.2K +2,047 +18%
Two Sigma Investments
71
Two Sigma Investments
New York
$142K -$1.1M -85,774 -88%
Legal & General Group
72
Legal & General Group
United Kingdom
$137K +$3.07K +240 +2%
Susquehanna International Group
73
Susquehanna International Group
Pennsylvania
$137K +$148K +11,578 New
BCM
74
BlueCrest Capital Management
Jersey
$126K +$137K +10,693 New
CC
75
Cannell & Co
New York
$118K – – –
1 2
3
4 5

GNMK Hedge Fund Activity: Q2 2017 in Review

99 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q2 2017, worth a combined $657M — up 6.4% from $618M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new GNMK positions and 6 closed out — a net gain of 13 holders — while 50 added to existing stakes and 13 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $12.3M. The largest seller was Adage Capital Partners, cutting an estimated $8.31M.

  • 99 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q2 2017, up from 86 in Q1 2017.
  • Funds reported $657M of GenMark Diagnostics, Inc stock for Q2 2017, up 6.4% quarter-over-quarter.
  • 19 funds opened new GenMark Diagnostics, Inc positions in Q2 2017 and 6 closed out, a net change of +13 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q2 2017 was Fidelity Investments, an estimated $12.3M added.
  • The largest GenMark Diagnostics, Inc seller in Q2 2017 was Adage Capital Partners, an estimated $8.31M sold.

Based on aggregated 13F filings for Q2 2017.